Why should we track development assistance for reproductive, maternal, newborn, and child health (RMNCH)? There is no single answer to this question, and therefore no single way to do it. In The Lancet Global Health, Antonia Dingle and colleagues report the convening of a group of policy makers to discuss why we should track financing for RMNCH. The group developed a set of principles guiding what information an aid tracking tool would ideally include. The authors present this tool—the Muskoka2 method—for tracking RMNCH aid, along with estimates of RMNCH development assistance from 2002 to 2017.

中文翻译：

---

在生殖，孕产妇，新生儿和儿童健康方面，什么算作发展援助？

我们为什么要跟踪对生殖，孕产妇，新生儿和儿童健康（RMNCH）的发展援助？这个问题没有单一的答案，因此没有单一的解决方法。在《柳叶刀全球卫生》中，安东尼娅·丁格（Antonia Dingle）及其同事报告了一组决策者的召集，讨论我们为什么要追踪RMNCH的融资。该小组制定了一套原则，指导援助追踪工具理想地包含哪些信息。作者介绍了用于跟踪RMNCH援助的此工具（Muskoka2方法），以及2002年至2017年对RMNCH开发援助的估计。